| Name | Title | Contact Details |
|---|
Artist Partner Group (APG) is a record label and music publishing company based in Los Angeles, California. Founded in 2013 by Mike Caren, APG initially operated as a joint venture with Atlantic Records and Warner Music Group. In November 2020, it became an independent entity after Atlantic Records acquired its catalog and roster. APG focuses on music publishing and record label operations, providing a platform for artists and songwriters to create and distribute music. The company emphasizes partnership and creativity, offering concierge-level creative services to support its writers. APG has played a significant role in the careers of various notable artists, including YoungBoy Never Broke Again, Charlie Puth, and Kehlani. The parent company of APG is Artist Publishing Group, also founded by Mike Caren, with distribution managed by Warner ADA.
Argo Group is a U.S.-focused underwriter of specialty insurance products in the property and casualty market. We offer a full line of products and services designed to meet the unique coverage and claims-handling needs of businesses. Since 1957, we share a firm commitment to working together with independent agents, wholesale brokers and retail brokerage partners to deliver innovative products for niche markets. Headquartered in New York, were a diverse company with multiple offices in the United States. Our belief that the companys success is linked to our employees drives our commitment to creating an environment and culture of respect where everyone can thrive. We value helping the communities around us, growing alongside our employees through innovation and creating a workplace with work-life balance. Fraud Alert Argo Group is aware of a fraud scam involving false job postings and unsolicited employment offers using our brand. These communications often include hyperlinks and request personal information. If you have any questions about the legitimacy of a job posting, please view all openings here on our website. If you are approached by someone claiming to represent Argo Group, please contact us at either (888) 864-3422 or siuconsults@argogroupus.com.
Public Risk Innovation, Solutions, and Management, PRISM, is a member-directed risk sharing pool of counties and public entities committed to providing risk coverage programs and risk management services.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Structure and develop real eastate and other hard asset deals.